title: Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin.
abstract: A letter in response to: Andersson ML, Eliasson E, Lindh JD. A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele. Pharmacogenomics 13(7), 757-762 (2012).
authors.forename: Mariana Rodrigues
authors.initials: MR
authors.lastname: Botton
authors.forename: Mara Helena
authors.initials: MH
authors.lastname: Hutz
authors.forename: Guilherme
authors.initials: G
authors.lastname: Suarez-Kurtz
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D019821:Simvastatin / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D014859:Warfarin; D019821:Simvastatin; D001189:Aryl Hydrocarbon Hydroxylases